Sort
40,608 grants matching “prostate cancer”
Gut bacterial metabolism of the side-chain of corticosteroids
$352,234Jason Michael Ridlon · University Of Illinois At Urbana-Champaign · R01 · FY2024 · GM
Adaptive resistance to HIF1a inhibition in hypoxia
$352,232Zheng David Qian · Oregon Health & Science University · R01 · FY2020 · CA
Core B - Animal Core
$352,232Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2021 · CA
Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit
$352,231Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Investigate role of microRNA cluster 183-96-182 in DNA repair and radiosensitivit
$352,231Dipanjan Chowdhury · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Telomeres, telomerase and chemotherapy: Bench to bedside
$352,225Jessie L.-S. Au · Optimum Therapeutics, Llc · R01 · FY2010 · CA
Core B - Animal Core
$352,221Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2020 · CA
NOVEL CYTOTOXIC NATURAL PRODUCTS FROM MARINE SPONGES
$352,215University Of California Santa Cruz · R01 · FY2002 · CA
Biomarkers for Prostate and Bladder Cancer
$352,214Alvin Y Liu · University Of Washington · U01 · FY2008 · CA
Insulin-like Growth Factor Axis and Insulin Resistance in PCPT
$352,167Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
Adaptive resistance to HIF1a inhibition in hypoxia
$352,147Zheng David Qian · Oregon Health & Science University · R01 · FY2017 · CA
Accuracy of Physical Activity Measures in Cancer Studies
$352,092Barbara Sternfeld · Kaiser Foundation Research Institute · R01 · FY2009 · CA
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
$352,047Guocan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer
$352,047Min Sup Song · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
TUCOE For Health Disparities Research and Training (HDRT
$352,020Temple University · R24 · FY2004 · MD
NEW AWARD: MULTIPLEX FUNCTIONAL INTERROGATION OF COMBINATIONS OF GENETIC ALTERATIONS IN PROSTATE CANCER...EFFECTIVE 2/1/2020 SIGNED 1/21/2020 DISTRIBUTED 1/22/2020, FAADC 1/22/2020
$351,997Fred Hutchinson Cancer Research Center · · FY2020 · Defense Health Agency
Designing a transcriptome-based, targeted theranostic platform for prostate cancer
$351,955Renata Pasqualini · Rutgers Biomedical And Health Sciences · R01 · FY2023 · CA
Designing a transcriptome-based, targeted theranostic platform for prostate cancer
$351,955Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2022 · CA
Dissecting the Role of Proteostasis in Anti-Androgen Resistant Prostate Cancer
$351,955Chengfei Liu · University Of California At Davis · R37 · FY2023 · CA
Metalloreductases in Medicine
$351,943Mark D Fleming · Boston Children'S Hospital · R01 · FY2008 · DK
Metalloreductases in Medicine
$351,943Mark D Fleming · Boston Children'S Hospital · R01 · FY2009 · DK
Heparan Sulfate Proteoglycans in Bone Stromal Metastasis
$351,931Mary C Farach-Carson · Cedars-Sinai Medical Center · P01 · FY2013 · CA
Studies of Protein Glycosylation
$351,922Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2011 · GM
Project 1: Non-Invasive Clinical Assay for Early Detection of Treatment Resistance in Patients with Metastatic Prostate Cancer
$351,884Himisha Beltran · Weill Medical Coll Of Cornell Univ · P50 · FY2017 · CA
CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors
$351,876Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2013 · CA